Featured Research

from universities, journals, and other organizations

Ventilators Biggest Risk Factor For Pneumonia After Heart Surgery, Study Finds

Date:
May 6, 2009
Source:
Critical Care
Summary:
Ventilator-associated pneumonia is the main cause of nosocomial infection in patients undergoing major heart surgery. An international study of 25 hospitals from 8 European countries has confirmed the degree of danger posed by VAP and identified the main risk factors.

Ventilator-associated pneumonia (VAP) is the main cause of nosocomial infection in patients undergoing major heart surgery. An international study of 25 hospitals from 8 European countries has confirmed the degree of danger posed by VAP and identified the main risk factors.

Related Articles


Javier Hortal, from the Hospital General Universitario Gregorio Marañón, worked with the European Study Group on Nosocomial Infections (ESGNI) and the European Workgroup of Cardiothoracic Intensivists (EWCI) to carry out a prospective study of 971 patients undergoing major heart surgery. They found that 4.4% acquired some form of nosocomial infection and VAP accounted for almost half of these (2.1%). According to Hortal, "The crude mortality rate of patients with VAP in our study was found to be 35%, this is significantly more than the mortality rate of 2.3% seen in patients who avoided VAP. The overall mortality rate for VAP in patients undergoing MHS may be as high as 16-57%, but many critically ill patients with VAP die because of their underlying disease rather than of pneumonia, which makes analysis difficult."

The authors found that, apart from the amount of time spent on mechanical ventilation, other risk factors for the development of VAP included transfusion requirements, type of surgery and the need for re-intervention for haemorrhage or cardiac tamponade in the immediate postoperative period. Hortal said, "Most unfortunately, the majority of the variables that significantly predict VAP are not amenable to intervention."

The authors recommend that anticipative or pre-emptive antimicrobial therapy should be explored as one of the few potential interventions to avoid VAP in patients remaining under mechanical ventilation for more than 48 hours.


Story Source:

The above story is based on materials provided by Critical Care. Note: Materials may be edited for content and length.


Journal Reference:

  1. Javier Hortal, Patricia Muñoz, Gregorio P Cuerpo, Héctor Litvan, Peter M Rosseel, Emilio Bouza, the European Study Group on Nosocomial Infections and the European Workgroup of Cardiothoracic Intensivists. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Critical Care, (in press)

Cite This Page:

Critical Care. "Ventilators Biggest Risk Factor For Pneumonia After Heart Surgery, Study Finds." ScienceDaily. ScienceDaily, 6 May 2009. <www.sciencedaily.com/releases/2009/04/090429205601.htm>.
Critical Care. (2009, May 6). Ventilators Biggest Risk Factor For Pneumonia After Heart Surgery, Study Finds. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2009/04/090429205601.htm
Critical Care. "Ventilators Biggest Risk Factor For Pneumonia After Heart Surgery, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2009/04/090429205601.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins